Arisaph Pharmaceuticals

About:

Arisaph Pharmaceuticals is focused on the development of therapies for cancer, cardiovascular disease, and diabetes.

Description:

Arisaph Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing therapies for cancer, cardiovascular disease, and diabetes. Its products include dipeptidylpeptidase IV inhibitors, stable GLP-1 agonists, HDL modulators and plaque reducers, and tumor activated pro-soft drugs. The company was founded in 1999 and is based in Boston, Massachusetts.

Total Funding Amount:

$10M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)arisaph.com

Founders:

Christopher P. Kiritsy, William Bachovchin

Number of Employees:

11-50

Last Funding Date:

2013-11-01

IPO Status:

Private

Industries: